# Differential Risks for Melanoma: p16 and DNA Repair

> **NCT00615095** · — · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 323 (actual)

## Conditions studied

- Melanoma
- Skin Melanoma

## Interventions

- **OTHER:** self-administered questionnaire and blood draw
- **OTHER:** self-administered questionnaire and blood draw
- **OTHER:** health questionnaire, blood draw and skin exam

## Key facts

- **NCT ID:** NCT00615095
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1997-02
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 323 (ACTUAL)
- **Last updated:** 2011-04-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00615095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00615095, "Differential Risks for Melanoma: p16 and DNA Repair". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00615095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*